Listening to Grandma's Revolutionary Story, Jinhua Pharmaceutical Company Organized Party Building Activities
Release time:
2023-07-26
Kaihua County, Quzhou City is a mountain city with a glorious revolutionary tradition, leaving countless footprints of revolutionary ancestors and many revolutionary sites. Fang Zhimin and other revolutionaries of the older generation established the Fujian, Zhejiang and Jiangxi revolutionary base in Kaihua. On July 7, 1936, after the victory of the Independent Regiment of the Red Army in attacking Kaihua County, the Anhui-Zhejiang-Jiangxi Provincial Committee established the Zhejiang-Anhui Special Committee in Fuling Mountain, Chaijia Village, Hetian Township, Kaihua County, in order to strengthen the leadership of the party. The first prefecture-level organization established by the party in Zhejiang during the Revolutionary War. Granny Lin Cui'e said that the local area is connected to Wuyuan in Jiangxi in the west and Xiuning in Anhui in the north. It is more than 500 meters above sea level. The independent regiment of the Red Army stationed in the village at that time, together with the Kaihua guerrillas, carried out an arduous guerrilla struggle on the border between Anhui, Zhejiang and Jiangxi. The grandmother is a volunteer red commentator. For more than 30 years, she has volunteered to explain to tourists from all over the country the establishment of the Zhejiang-Anhui Special Committee and its struggle, and the revolutionary deeds of the anti-Japanese advance team fighting in Kaihua every day at the former site of the Zhejiang-Anhui Special Committee of the Communist Party of China. Today, at the age of 96, she still insists on serving as a red commentator at the former site of the Zhejiang-Anhui Special Committee of the Communist Party of China, spending her life telling red stories and spreading the voice of the party.
In order to thoroughly implement the spirit of the 20th National Congress of the Communist Party of China, carry out the theme education of learning Xi Jinping's new era of socialism with Chinese characteristics, encourage all party members to play a vanguard and exemplary role, and guide party members and cadres to dare to be the first. Celebrating the 102 anniversary of the founding of the Communist Party of China, the general party branch of the pharmaceutical company launched this red education activity of "follow the footprints to understand the truth, courageously and seek development, organize party members and cadres to follow the footsteps of their ancestors, relive the extraordinary years, carry forward the legacy of the martyrs, and lead the party flag to forge ahead and continue to develop. (Fan Tufa)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31